CatalystWireBeta

Form 8 (DD) - Spire Healthcare Group plc

In brief · summary, not quotable

Bridgemere Securities Limited, acting in concert with the Offeror concerning Spire Healthcare Group Plc, has disclosed a sale of 22,435,739 ordinary shares at 245 pence per share on September 8, 2026. This announcement replaces previous disclosures and follows a Panel Statement released on September 11, 2026. Following this transaction, Bridgemere Securities Limited holds zero relevant securities and has no disclosed short positions or rights to subscribe for new securities in Spire Healthcare Group Plc.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your SPI notes

Amendment - this form replaces RNS 0992U published at 15:25 on 09/09/26 & RNS 1253U published at 17:30 on 09/09/26 following the Panel Statement 2026/12 released at 14:30 on 11/09/26

KEY INFORMATION

(a) Full name of discloser:BRIDGEMERE SECURITIES LIMITED
(e) Date dealing undertaken:8 SEPTEMBER 2026
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
Class of relevant security:
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:00
  • Cash-settled derivatives:
  • Stock-settled derivatives (including options) and agreements to purchase/sell:
(a) Full name of discloser:BRIDGEMERE SECURITIES LIMITED
(e) Date dealing undertaken:8 SEPTEMBER 2026
TOTAL:00

All interests and all short positions should be disclosed.

  • Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

DEALINGS BY THE PERSON MAKING THE DISCLOSURE

The currency of all prices and other monetary amounts should be stated.

Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
1p OrdinarySALE22,435,739245p
Class of relevant securityPurchases/ salesTotal number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
(b) Cash-settled derivative transactions
Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
(ii) Exercise
Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
(d) Other dealings (including subscribing for new securities)
Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
  • OTHER INFORMATION
  • Indemnity and other dealing arrangements
  • Agreements, arrangements or understandings relating to options or derivatives
  • Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)NO
Supplemental Form 8 (SBL)NO
Date of disclosure:11 SEPTEMBER 2026

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note